Cargando…

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma

A clinically relevant subset of patients with soft tissue sarcoma presents with either locally advanced or upfront metastatic disease, or will develop distant metastases over time, despite successful treatment of their primary tumour. The currently available systemic agents to treat such advanced ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yannick, Wozniak, Agnieszka, Cornillie, Jasmien, Avilés, Pablo, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267286/ https://www.ncbi.nlm.nih.gov/pubmed/35806460 http://dx.doi.org/10.3390/ijms23137454

Ejemplares similares

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
por: Cornillie, Jasmien, et al.
Publicado: (2019)

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models()()()
por: Li, Haifu, et al.
Publicado: (2014)

Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014)

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models()()
por: Van Looy, Thomas, et al.
Publicado: (2015)

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

A Sarcoma at the Site of Previous Extravasation of Adriamycin
por: Ceulemans, Joris, et al.
Publicado: (2002)

Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial
por: Lee, Che-Jui, et al.
Publicado: (2022)

Case report: Cardiac intimal sarcoma in a young child
por: Verbeek, Sanne, et al.
Publicado: (2023)

Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial
por: Lee, Che-Jui, et al.
Publicado: (2021)

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells
por: Galmarini, Carlos M., et al.
Publicado: (2018)

A rare case of atypical/anaplastic meningioma with MDM2 amplification
por: Wylleman, Robbert, et al.
Publicado: (2018)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research
por: Lee, Che-Jui, et al.
Publicado: (2021)

Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location
por: Wyn, Inez, et al.
Publicado: (2014)

Effect of the Marine Polyketide Plocabulin on Tumor Progression
por: Turrini, Eleonora, et al.
Publicado: (2022)

Frequent activation of EGFR in advanced chordomas
por: Dewaele, Barbara, et al.
Publicado: (2011)

MDM2 Amplified Sarcomas: A Literature Review
por: Sciot, Raf
Publicado: (2021)

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
por: Prenen, Hans, et al.
Publicado: (2015)

Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin
por: Pantazopoulou, Areti, et al.
Publicado: (2018)

Clinical implications of mutational analysis in gastrointestinal stromal tumours
por: Hoeben, A, et al.
Publicado: (2008)

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs
por: Amirnasr, Azadeh, et al.
Publicado: (2019)

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models
por: Heredia-Soto, Victoria, et al.
Publicado: (2022)

Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
por: Mahale, S, et al.
Publicado: (2015)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.
por: Kerr, D. J., et al.
Publicado: (1988)

A phase II trial with rosiglitazone in liposarcoma patients
por: Debrock, G, et al.
Publicado: (2003)

Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
por: Chang, Qing, et al.
Publicado: (2010)

Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay
por: Costales-Carrera, Alba, et al.
Publicado: (2019)

Downstream and Intermediate Interactions of Synovial Sarcoma-Associated Fusion Oncoproteins and Their Implication for Targeted Therapy
por: Przybyl, Joanna, et al.
Publicado: (2012)

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients
por: Huygh, G., et al.
Publicado: (2006)

Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
por: Rausch, Jessica L., et al.
Publicado: (2020)

Pathogenesis of vestibular schwannoma in ring chromosome 22
por: Denayer, Ellen, et al.
Publicado: (2009)

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
por: Ge, Shushan, et al.
Publicado: (2020)

Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models
por: Forde, P F, et al.
Publicado: (2015)

STAMBPL1 knockdown has antitumour effects on gastric cancer biological activities
por: Yu, Da-Jun, et al.
Publicado: (2019)

Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features
por: Mertens, Fredrik, et al.
Publicado: (2011)

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
por: Gits, C M M, et al.
Publicado: (2013)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_79203tc7thoe1ie0m9e2c9ui2s